Authors
Loading...
Evaluation reveals FAP as a prognostic biomarker for poor outcomes in advanced ccRCC, indicating resistance to TKIs.
Montes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: